• 제목/요약/키워드: carcinoembryonic antigen (CEA)

검색결과 100건 처리시간 0.028초

Alpha-fetoprotein (AFP) Elevation Gastric Adenocarcinoma and Importance of AFP Change in Tumor Response Evaluation

  • Tatli, Ali Murat;Urakci, Zuhat;Kalender, Mehmet Emin;Arslan, Harun;Tastekin, Didem;Kaplan, Mehmet Ali
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권5호
    • /
    • pp.2003-2007
    • /
    • 2015
  • Background: Elevated serum alpha-fetoprotein (AFP) levels in adults are considered abnormal. This parameter is used mostly in the diagnosis and follow-up of hepatocellular carcinomas and yolk sac tumors. Among the other rare tumors accompanied with elevated serum AFP levels, gastric cancer is the most common. In this study, we evaluated the follow-up and comparison of the treatment and marker response of patients with metastatic gastric cancer who had elevated serum AFP levels. Materials and Methods: We performed a retrospective study, including all consecutive patients with advanced gastric cancer, who received systemic chemotherapy with elevated AFP level. Results: Seventeen metastatic gastric cancer patients with elevated AFP levels at the time of diagnosis were evaluated. Fourteen (82.4%) were males and three (17.6%) were females. The primary tumor localization was the gastric body in 8 (76.4%), cardia in 7 (41.2%), and antrum in 2 (11.8%). Hepatic metastasis was observed in 13 (76.4%) at the time of diagnosis. When the relationship of AFP levels and carcinoembryonic antigen (CEA) response of the patients with their radiologic responses was evaluated, it was found that the radiologic response was compatible with AFP response in 16 (94.1%) patients and with CEA response in 12 (70.6%); however, in 5 (29.4%) patients no accordance was observed between radiological and CEA responses. Conclusions: Follow-up of AFP levels in metastatic gastric cancer patients with elevated AFP levels may allow prediction of early treatment response and could be more useful than the CEA marker for follow-up in response evaluation.

종양 표지 인자로서 혈장 Transforming Growth Factor-β1에 대한 연구 (Study of plasma transforming growth factor-β1 level as a useful tumor marker in various cancers)

  • 신훈;임창기;최인영;이두연;노동영;류민희;이효석;방영주;박종섭;진승원
    • IMMUNE NETWORK
    • /
    • 제1권2호
    • /
    • pp.143-150
    • /
    • 2001
  • Background : Many investigators have found transforming growth factor-${\beta}1$ (TGF-${\beta}1$) to be elevated in tumors. Changes in responsiveness to TGF-${\beta}1$ have been linked to malignant transformation, tumor progression and tumor regression. Many malignant cell lines of epithelial or hematopoietic origin are refractory to the antiproliferative effects of TGF-${\beta}1$. However, a little is known about the association of TGF-${\beta}1$ with progression of malignant tumor. Methods : In this study, we measured the plasma level of TGF-${\beta}1$ in various cancer patients and evaluated the utility of plasma TGF-${\beta}1$ as a possible tumor marker. Plasma TGF-${\beta}1$ levels were measured using enzyme-linked immunosorbent assay in cancer patients and normal controls. Carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) as tumor marker were compared with TGF-${\beta}1$ in the aspects of sensitivity and specificity. Results : The mean of plasma TGF-${\beta}1$ levels was $1.219{\pm}0.834ng/ml$ in normal controls, $5.491{\pm}3.598ng/ml$ in breast cancer, $12.670{\pm}10.386ng/ml$ in lung cancer, $5.747{\pm}3.228ng/ml$ in hepatocellular carcinoma and $10.854{\pm}7.996ng/ml$ in cervical cancer. In comparison with CEA and AFP, TGF-${\beta}1$ is more sensitive. Conclusion : We conclude that the high levels of TGF-${\beta}1$ are common in the plasma of cancer patients. These results suggest that the plasma TGF-${\beta}1$ level can be a potent tumor marker in various cancer patients.

  • PDF

악성 흉막액에서 CEA와 CYFRA 21-1의 진단적 유용성 (Diagnostic Utility of Pleural Fluid CEA and CYFRA 21-1 for Malignant Pleural Effusions)

  • 정재호;최정은;박무석;황상연;문진욱;김영삼;장준;김주항;김성규;김세규
    • Tuberculosis and Respiratory Diseases
    • /
    • 제57권1호
    • /
    • pp.32-36
    • /
    • 2004
  • 목 적 : 악성 흉막액의 진단을 위해서는 흉막액 세포진 검사, 흉막 생검 등이 이용되지만 위음성의 문제가 있어서 이를 보완하기 위해서 지금까지 여러 종양 표지자들이 흉막액에서 측정되어 왔다. 저자 등은 흉막액의 감별진단에 널리 알려진 CEA와 최근에 소개된 CYFRA 21-1의 진단적 유용성에 대해 알아보기 위해 본 연구를 시행하였다. 방 법 : 2002년 4월부터 2003년 11월까지 흉막액으로 내원한 222예(양성 150예, 폐암 57예, 전이성암 15예)를 대상으로 하여 전향적으로 혈청과 흉막액에서 CEA와 CYFRA 21-1를 각각 측정하였다. 결 과 : 양성 흉막액에 비해 악성 흉막액에서 유의하게 CEA와 CYFRA 21-1값이 높았으며, 특이도를 95%로 하였을 때 흉막액 CEA와 CYFRA 21-1의 cut off 값은 각각 5, 89 ng/ml 이었고 민감도는 각각 72%, 54%이었다. 흉막액에서 CEA와 CYFRA 21-1를 병용하여 검사했을 때의 민감도는 87%로 CEA나 CYFRA 21-1 단독검사에 비해 유의하게 높게 나타났다(p<0.05). 결 론 : 흉막액 CEA와 CYFRA 21-1 검사의 병용은 악성흉막액의 진단에 유용할 것으로 생각된다.

자궁 경부암 환자의 추적검사시 혈장내 CEA치 측정의 임상적 의의 (Clinical Significance of Plasma CEA Levels in the Patients with Cervical Carcinoma during Follow-Up)

  • 반성범;김주영;최명선;나중열;이민재
    • Radiation Oncology Journal
    • /
    • 제9권2호
    • /
    • pp.293-301
    • /
    • 1991
  • CEA 측정으로 부인과 영역 악성종양의 치료결과나 재발 여부의 조기 진단을 할 수 있나를 연구한 결과이다. 1985년 1월부터 1989년 12월까지 239명의 자궁경부암 환자를 대상으로 치료전과 치료후 CEA치를 체계적으로 측정했고 이를 비교하기 위하여 정상군으로 아무런 증상이 없는 건강한 부인 65명과 양성종양을 가진 18명의 부인을 상대로 CEA치를 측정하였다. 혈장내 CEA치는 종양의 진행정도와 기의 직접관계가 있는 것을 알 수 있고 종양의 기가 진행되면 될수록 CEA치가 비정상인 경우가 높아지고 있다. 또한 CEA치가 비정상인 경우 편평상피종 환자보다는 선세포나 선세포와 편평세포가 혼합된 경우 더욱 증가되는 것을 볼 수 있었다. 결론으로 혈장내 CEA을 체계적으로 측정함으로써 치료 끝난 후 추적검사시 재발의 조기발견 및 치료결과를 확인할 수 있는 좋은 방법이라는 결론을 얻었다.

  • PDF

핵의학 체외 검사에서 자동분주기를 이용한 Random Assay 가능성평가 (Comparison of Batch Assay and Random Assay Using Automatic Dispenser in Radioimmunoassay)

  • 문승환;이호영;신선영;민경선;이현주;장수진;강지연;이동수;정준기;이명철
    • Nuclear Medicine and Molecular Imaging
    • /
    • 제43권4호
    • /
    • pp.323-329
    • /
    • 2009
  • 목적: 방사면역측정법 및 면역방사계수법은 매 실험마다 표준용액을 넣고 표준곡선에 대비하여 결과를 산출하는 batch assay가 일반화되어 있다. 비용과 시간에 대한 효율성을 증가 시키기 위해서는 선행 표준 곡선을 이용하여 검사를 진행하는 random assay의 적용이 요구된다. 방사면역측정법 및 면역방사계수법에서 자동분주기를 이용한 random assay적용 가능성을 평가 하기 위해 본 연구를 수행하였다. 대상 및 방법: Triiodothyronine (T3), free thyroxine (fT4), Prostate specific antigen (PSA), Carcinoembryonic antigen (CEA) 4가지 항목을 대상으로 하였으며 각 검사별 20명의 환자 검체를 이용하였다. 각 검사 항목별로 표준곡선을 얻기 위해 3시간 간격으로 4회 측정한 표준용액의 분당계수값(counter per minute, cpm)을 측정하였다. 이를 Friedman test를 이용하여 비교하여 검사시 마다 얻는 표준 곡선간의 차이를 평가하였다. 각 검사별 저, 중, 고농도의 대조 용액을 이용하여 5회 측정하고 이를 Friedman test를 이용하여 비교하여 측정 내 정밀도를 평가하였다. 각 검사별 저, 중, 고농도의 대조용액을 batch assay와 자동분주기를 이용한 random assay로 3시간 간격으로 각각 4회 측정하였다. 측정값을 바탕으로 평균, 표준 편차, 변이계수를 구하고 Wilcoxon test를 이용하여 비교하여 assay 방법에 따른 차이를 비교하였다. 두 assay간에 일치도(agreement)를 평가하기 위해 두 assay의 측정값 사이에 급내상관계수(Intraclass correlation coefficient, ICC)와 상관계수를 계산하였다. 결과: 모든 검사항목에서 표준 용액의 분당계수값은 측정 간에 통계적으로 유의한 차이가 없었다. T3, fT4, PSA, CEA 검사항목마다 측정한 저, 중, 고농도별 측정 내 변이계수는 T3(3.6%, 2.6%, 0.9%), fT4(4.5%, 1.1%. 1.3%), PSA(3.9%, 3.1%, 1.2%), CEA(5.0%, 4.8%, 7.6%)였다. 검사 항목별 측정방법에 따른 대조 용액을 이용한 표준 곡선의 측정 간 정밀도 평가에서 두 검사 방법간에 유의한 차이가 없었다. 각 검사항목별로 20명의 환자 검체에서 측정한 측정 간 변이계수(inter-assay precision)의 평균과 표준편차 값은 batch assay로 시행했을 때 각각 3.2$\pm$1.7%, 3.9$\pm$2.1%. 7.1$\pm$6.2%, 11.2$\pm$7.2%였고 random assay로 측정하였을 때는 2.7$\pm$1.7%, 4.8$\pm$3.1%, 3.6$\pm$4.8%, 7.4$\pm$6.2였다. Batch assay와 random assay는 서로 높은 일치도를 보였다. 측정한 급내상관계수(Intraclass correlation coefficient)는 T3, fT4, PSA, CEA 각각 0.9968, 0.9973. 0.9996, 0.9901였다. Batch assay로 측정한 값과 자등분주기를 이용한 random assay로 측정한 값 사이에 상관 계수(R$^2$)는 T3, fT4, PSA, CEA 각각 0.9924, 0.9974, 0.9994, 0.9989(p<0.005)로 모두 강한 상관관계를 보였다. 결론: T3, fT4, PSA, CEA 4가지 항목의 방사면역측정 법 (Radioimmunoassay)에서 기존의 batch assay와 자동분주기를 이용한 random assay간에 일치도와 상관성이 높았다. 결론적으로 자동분주기를 이용한 random assay를 방사면역측정법 및 면역방사계수법에 적절히 이용할 수 있을 것으로 생각된다.

Metastatic Thymic Adenocarcinoma from Colorectal Cancer

  • Lee, Mina;Choi, Suk Jin;Yoon, Yong Han;Kim, Joung-Taek;Baek, Wan Ki;Kim, Young Sam
    • Journal of Chest Surgery
    • /
    • 제48권6호
    • /
    • pp.447-451
    • /
    • 2015
  • This report describes the case of a 57-year-old man with an anterior mediastinal tumor. Four years previously, he underwent laparoscopic anterior resection for sigmoid colon cancer. Thirty months after that procedure, bilateral pulmonary metastasectomy was performed. Twelve months later, follow-up computed tomography revealed a 1-cm pulmonary nodule on the upper lobe of the right lung and a solid mass on the anterior mediastinum, and the patient was also observed to have an elevated serum carcinoembryonic antigen (CEA) level. Repeated pulmonary nodule resection and total thymectomy were performed. Immunohistochemical staining of the anterior mediastinal tumor revealed adenocarcinoma, and his serum CEA level returned to normal after the operation. These findings strongly suggested metastatic thymic adenocarcinoma from a colorectal cancer.

Expression and Significance of TSGF, CEA and AFP in Patients Before and after Radical Surgery for Colon Cancer

  • Hu, Yi;Wang, Jing-Liang;Tao, Hai-Tao;Wu, Bai-Shou;Sun, Jin;Cheng, Yao;Dong, Wei-Wei;Li, Rui-Xin
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권6호
    • /
    • pp.3877-3880
    • /
    • 2013
  • Objective: To explore the expression and significance of tumor specific growth factor (TSGF), carcinoembryonic antigen (CEA) and alpha fetoprotein (AFP) in cancer tissue and serum of patients with colon cancer. Materials and Methods: Radical surgery for colon cancer was performed on 43 patients with laparoscopu under conditions of general anesthesia. The Elisa method was used to detect the levels of serum TSGF, CEA and AFP before and after radical operation, and cancer tissue underwent TSGF, CEA and AFP immunohistochemistry staining after laparoscopic surgery. The decreased conditions of serum TSGF, CEA and AFP in patients with colon cancer at different levels of differentiation and clinical stagings were analyzed, and the relationships of expression rates between histological types, colon cancer morphology, lymph node metastasis and TSGF, CEA as well as AFP in cancer tissue were assessed. Results: Compared with before radical surgery, the levels of serum TSGF, CEA and AFP decreased notably in patients after operations (p<0.01). The decreased degree of TSGF and CEA was the largest in patients with poorly differentiated cancer tissue (p<0.01), while that of AFP was noted in patients with moderately differentiated cancer tissue (p<0.01). The decreased degree of TSGF and AFP was the largest in patients at phase Dukes A (p<0.01), while that of CEA in patients at phase Dukes C (p<0.01). There were no significant differences among the positive expression rates of TSGF, CEA and AFP with different histological types and colon cancer morphologies (p>0.05). The positive expression rates of TSGF and CEA in patients with lymph node metastasis were significantly higher than those without lymph node metastasis (p<0.01). Conclusions: TSGF, CEA and AFP can be used to evaluate the effect of radical operation for colon cancer, and the changed levels of different markers are associated with tumor differentiation, clinical stating and presence or absence of lymph node metastasis.

판정행렬을 기반한 일체형 PET-MRI의 폐암 진단 유용성 평가 (Evaluation of Usefulness for Diagnosis of Lung Cancer on Integrated PET-MRI Using Decision Matrix)

  • 김정수;양현진;김유미;권형진;박찬록
    • 대한방사선기술학회지:방사선기술과학
    • /
    • 제44권6호
    • /
    • pp.635-643
    • /
    • 2021
  • The results of empirical researches on the diagnosis of lung cancer are insufficient, so it is limited to objectively judge the clinical possibility and utilization according to the accuracy of diagnosis. Thus, this study retrospectively analyzed the lung cancer diagnostic performance of PET-MRI (Positron Emission Tomography-Magnetic Resonance Imaging) by using the decision matrix. This study selected and experimented total 165 patients who received both hematological CEA (Carcinoembryonic Antigen) test and hybrid PET-MRI (18F-FDG, 5.18 MBq/kg / Body TIM coil. VIVE-Dixon). After setting up the result of CEA (positive:>4 ㎍/ℓ. negative:<2.5㎍/ℓ) as golden data, the lung cancer was found in the image of PET-MRI, and then the SUVmax (positive:>4, negative:<1.5) was measured, and then evaluated the correlation and significance of results of relative diagnostic performance of PET-MRI compared to CEA through the statistical verification (t-test, P>0.05). Through this, the PET-MRI was analyzed as 96.29% of sensitivity, 95.23% of specificity, 3.70% of false negative rate, 4.76% of false positive rate, and 95.75% of accuracy. The false negative rate was 1.06% lower than the false positive rate. The PET-MRI that significant accuracy of diagnosis through high sensitivity and specificity, and low false negative rate and false positive rate of lung cancer, could acquire the fusion image of specialized soft tissue by combining the radio-pharmaceuticals with various sequences, so its clinical value and usefulness are regarded as latently sufficient.

지방유래 줄기세포의 생존능 향상을 위한 CEACAM 6의 생물학적 기능에 대한 연구 (Biological Function of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6 for the Enhancement of Adipose-Derived Stem Cell Survival against Oxidative Stress)

  • 고은영;유지은;정세화;김평환
    • 대한임상검사과학회지
    • /
    • 제51권4호
    • /
    • pp.475-483
    • /
    • 2019
  • 세포기반 치료제에 사용되는 줄기세포는 재생능력과 다양한 세포로의 분화능력으로 인해 재생 의학 분야에서 광범위하게 관심을 끌었으며, 많은 불치병에 적용된다. 하지만, 이러한 줄기세포는 여전히 치료 전 세포증식 및 질병 투여부위에서의 낮은 생존률로 인해 충분한 치료효과가 나타나지 않는 단점이 있다. 이것을 해결하고자, 우리는 세포부착능과 항세포자살 기능을 가지고 있는 carcinoembryonic antigen (CEA) gene family의 하나인 CEACAM 6를 사용하였다. 이것을 줄기세포에 적용 전, 먼저 세포별로 이 단백질이 발현되는지를 확인하였고, 이 유전자가 발현되는 벡터를 줄기세포에 삽입시키기 위한 최적 조건을 선정하였다. 그 후, 도입된 CEACAM 6발현벡터로부터 줄기세포에서 이 유전자가 발현되는지를 확인하였다. 그리고 인체투여 시 발생되는 산화적 스트레스와 유사한 조건에서의 이 유전자의 기능을 평가하기 위해 과산화수소(H2O2)를 처리하였다. 산화적 스트레스 조건하에서 CEACAM 6가 발현되는 줄기세포는 그렇지 않은 세포에 비해 세포의 생존률이 현저히 증가하는 것을 확인하였다. 이를 통해, 이 CEACAM 6는 줄기세포의 치료효능과 세포증식을 강화시킬 수 있는 다른 선택지로서의 가능성이 있음을 확인하였다.

Bone Metastasis from Gastric Cancer: The Incidence, Clinicopathological Features, and Influence on Survival

  • Turkoz, Fatma Paksoy;Solak, Mustafa;Kilickap, Saadettin;Ulas, Arife;Esbah, Onur;Oksuzoglu, Berna;Yalcin, Suayib
    • Journal of Gastric Cancer
    • /
    • 제14권3호
    • /
    • pp.164-172
    • /
    • 2014
  • Purpose: To evaluate the incidence, clinicopathological characteristics, treatment outcomes, prognostic factors, and survival of gastric cancer patients with bone metastases. Materials and Methods: Of 4,617 gastric cancer patients who were treated between 2001 and 2013, 176 patients with bone metastases were analyzed. Results: The incidence of bone metastasis was 3.8%. The most common histopathological subtype was adenocarcinoma (79%) with poor differentiation (60.8%). The median interval from the diagnosis to bone metastasis was 11 months. The median survival time after bone metastasis was 5.4 months. Factors that were associated with longer median survival times included the following: isolated bone metastasis (P=0.004), well-differentiated tumors (P=0.002), palliative chemotherapy (P=0.003), zoledronic acid treatment (P<0.001), no smoking history (P=0.007), and no metastatic gastric cancer at the time of diagnosis (P=0.01). On the other hand, high levels of lactate dehydrogenase (LDH) (hazard ratio [HR]: 1.86; P=0.015), carcinoembryonic antigen (CEA) (HR: 2.04; P=0.002), and carbohydrate antigen (CA) 19-9 (HR: 2.94; P<0.001) were associated with shorter survival times. In multivariate analysis, receiving zoledronic acid (P<0.001) and performance status (P=0.013) were independent prognostic factors. Conclusions: Smoking history, poor performance status, poorly differentiated adenocarcinoma, and high levels of LDH, CEA, and CA 19-9 were shown to be poor prognostic factors, while receiving chemotherapy and zoledronic acid were associated with prolonged survival in gastric cancer patients with bone metastases.